https://www.selleckchem.com/pr....oducts/danirixin.htm
8 cohorts. The KAMIR-NIH risk score was developed from the model and corresponded well with observed MACEs very low risk (0.9%), low risk (1.7%), moderate risk (4.2%), high risk (8.6%), and very high risk (23.3%). In patients with MACEs, a KAMIR-NIH risk score≤10 was associated with high bleeding risk, whereas a KAMIR-NIH risk score10 was associated with high in-hospital mortality. The KAMIR-NIH in-hospital MACEs model using baseline variables stratifies comprehensive risk for in-hospital mortality and major bleeding, and is use
Like
Comment
Share
